Correlation Between Abcam Plc and Moleculin Biotech

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Abcam Plc and Moleculin Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Abcam Plc and Moleculin Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Abcam Plc ADR and Moleculin Biotech CS, you can compare the effects of market volatilities on Abcam Plc and Moleculin Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Abcam Plc with a short position of Moleculin Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Abcam Plc and Moleculin Biotech.

Diversification Opportunities for Abcam Plc and Moleculin Biotech

0.46
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Abcam and Moleculin is 0.46. Overlapping area represents the amount of risk that can be diversified away by holding Abcam Plc ADR and Moleculin Biotech CS in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Moleculin Biotech and Abcam Plc is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Abcam Plc ADR are associated (or correlated) with Moleculin Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Moleculin Biotech has no effect on the direction of Abcam Plc i.e., Abcam Plc and Moleculin Biotech go up and down completely randomly.

Pair Corralation between Abcam Plc and Moleculin Biotech

Given the investment horizon of 90 days Abcam Plc is expected to generate 1.06 times less return on investment than Moleculin Biotech. But when comparing it to its historical volatility, Abcam Plc ADR is 1.67 times less risky than Moleculin Biotech. It trades about 0.04 of its potential returns per unit of risk. Moleculin Biotech CS is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest  169.00  in Moleculin Biotech CS on May 9, 2022 and sell it today you would earn a total of  1.00  from holding Moleculin Biotech CS or generate 0.59% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Abcam Plc ADR  vs.  Moleculin Biotech CS

 Performance (%) 
       Timeline  
Abcam Plc ADR 
Abcam Performance
9 of 100
Compared to the overall equity markets, risk-adjusted returns on investments in Abcam Plc ADR are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Even with relatively conflicting fundamental indicators, Abcam Plc revealed solid returns over the last few months and may actually be approaching a breakup point.

Abcam Price Channel

Moleculin Biotech 
Moleculin Performance
9 of 100
Compared to the overall equity markets, risk-adjusted returns on investments in Moleculin Biotech CS are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of fairly conflicting basic indicators, Moleculin Biotech showed solid returns over the last few months and may actually be approaching a breakup point.

Moleculin Price Channel

Abcam Plc and Moleculin Biotech Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Abcam Plc and Moleculin Biotech

The main advantage of trading using opposite Abcam Plc and Moleculin Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Abcam Plc position performs unexpectedly, Moleculin Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Moleculin Biotech will offset losses from the drop in Moleculin Biotech's long position.

Abcam Plc ADR

Pair trading matchups for Abcam Plc

The idea behind Abcam Plc ADR and Moleculin Biotech CS pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Moleculin Biotech CS

Pair trading matchups for Moleculin Biotech

Check out your portfolio center. Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.

Other Complementary Tools

Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Go
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Go
Piotroski F Score
Get Piotroski F Score based on binary analysis strategy of nine different fundamentals
Go
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Go
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Go